Spero Therapeutics (SPRO) EBITDA Margin Growth (5y) (2021 - 2026)
Spero Therapeutics (SPRO) EBITDA Margin Growth (5y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Spero Therapeutics |
129.74 Mn |
73.61 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-265,569.00 |
| Sep 30, 2025 |
4.97 Mn |
| Jun 30, 2025 |
99,418.00 |
| Mar 31, 2025 |
111,859.00 |
| Dec 31, 2024 |
350,630.00 |
| Sep 30, 2024 |
-2.82 Mn |
| Jun 30, 2024 |
1.93 Mn |
| Mar 31, 2024 |
-8,554.00 |
| Dec 31, 2023 |
70,482.00 |
| Sep 30, 2023 |
12,115.00 |
| Jun 30, 2023 |
170,864.00 |
| Dec 31, 2022 |
155,616.00 |
| Sep 30, 2022 |
106,691.00 |
| Jun 30, 2022 |
248,205.00 |
| Mar 31, 2022 |
299,238.00 |
| Dec 31, 2021 |
-1.37 Mn |
| Sep 30, 2021 |
1.11 Mn |
